# BTG acquires Novate Medical for up to $150 million

British healthcare company BTG Plc acquired U.S. medical device maker Novate Medical for $20 million upfront and up to $130 million in milestone payments. Novate developed the Sentry vascular device for preventing pulmonary embolism.

- Type: Acquisition
- Announced: 2018-09-07
- Where: Galway, United States
- Value: $20.0M
- Status: completed
- Products: Sentry vascular device
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [BTG Plc](https://endata.com/companies/34199.md) (acquirer)
- [Novate Medical](https://endata.com/companies/34200.md) (target)

## Sources

- [sg.finance.yahoo.com](https://sg.finance.yahoo.com/news/british-healthcare-firm-btg-buys-084111056.html), 2018-09-07: "BTG has paid $20 million in cash to buy Novate, and may pay a further $130 million depending on the device hitting certain sales-related milestones"
- [serobavc.com](https://serobavc.com/novate-acquired-by-btg-for-up-to-150m/), 2018-09-07: "BTG has acquired Novate for a $20m upfront payment with additional potential milestones of up to $130m."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.